Surgical management for giant bladder leiomyosarcoma

While urothelial carcinoma is the most common histologic type of bladder cancer in the United States, leiomyosarcoma is a rare and aggressive variant. The rarity of bladder leiomyosarcoma results in uncertainty regarding the optimal treatment pathway. We report on a patient with a giant non-metastat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hart, Alexander A., Schlaepfer, Charles H., Dhungana, Neha, Milhem, Mohammed M., Packiam, Vignesh T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760472/
https://www.ncbi.nlm.nih.gov/pubmed/35059300
http://dx.doi.org/10.1016/j.eucr.2022.101995
_version_ 1784633327306670080
author Hart, Alexander A.
Schlaepfer, Charles H.
Dhungana, Neha
Milhem, Mohammed M.
Packiam, Vignesh T.
author_facet Hart, Alexander A.
Schlaepfer, Charles H.
Dhungana, Neha
Milhem, Mohammed M.
Packiam, Vignesh T.
author_sort Hart, Alexander A.
collection PubMed
description While urothelial carcinoma is the most common histologic type of bladder cancer in the United States, leiomyosarcoma is a rare and aggressive variant. The rarity of bladder leiomyosarcoma results in uncertainty regarding the optimal treatment pathway. We report on a patient with a giant non-metastatic bladder leiomyosarcoma effectively managed with primary surgical intervention without chemoradiation.
format Online
Article
Text
id pubmed-8760472
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-87604722022-01-19 Surgical management for giant bladder leiomyosarcoma Hart, Alexander A. Schlaepfer, Charles H. Dhungana, Neha Milhem, Mohammed M. Packiam, Vignesh T. Urol Case Rep Oncology While urothelial carcinoma is the most common histologic type of bladder cancer in the United States, leiomyosarcoma is a rare and aggressive variant. The rarity of bladder leiomyosarcoma results in uncertainty regarding the optimal treatment pathway. We report on a patient with a giant non-metastatic bladder leiomyosarcoma effectively managed with primary surgical intervention without chemoradiation. Elsevier 2022-01-07 /pmc/articles/PMC8760472/ /pubmed/35059300 http://dx.doi.org/10.1016/j.eucr.2022.101995 Text en © 2022 The Authors. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Oncology
Hart, Alexander A.
Schlaepfer, Charles H.
Dhungana, Neha
Milhem, Mohammed M.
Packiam, Vignesh T.
Surgical management for giant bladder leiomyosarcoma
title Surgical management for giant bladder leiomyosarcoma
title_full Surgical management for giant bladder leiomyosarcoma
title_fullStr Surgical management for giant bladder leiomyosarcoma
title_full_unstemmed Surgical management for giant bladder leiomyosarcoma
title_short Surgical management for giant bladder leiomyosarcoma
title_sort surgical management for giant bladder leiomyosarcoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760472/
https://www.ncbi.nlm.nih.gov/pubmed/35059300
http://dx.doi.org/10.1016/j.eucr.2022.101995
work_keys_str_mv AT hartalexandera surgicalmanagementforgiantbladderleiomyosarcoma
AT schlaepfercharlesh surgicalmanagementforgiantbladderleiomyosarcoma
AT dhungananeha surgicalmanagementforgiantbladderleiomyosarcoma
AT milhemmohammedm surgicalmanagementforgiantbladderleiomyosarcoma
AT packiamvignesht surgicalmanagementforgiantbladderleiomyosarcoma

Ejemplares similares